Haemophilus influenzae Isolated From Men With Acute Urethritis: Its Pathogenic Roles, Responses to Antimicrobial Chemotherapies, and Antimicrobial Susceptibilities
- 1 April 2017
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Sexually Transmitted Diseases
- Vol. 44 (4), 205-210
- https://doi.org/10.1097/olq.0000000000000573
Abstract
There have been few comprehensive studies on Haemophilus influenza–positive urethritis. In this retrospective study, we enrolled 68 men with H. influenzae–positive urethritis, including coinfections with Neisseria gonorrhoeae, Chlamydia trachomatis, and/or genital mycoplasmas: 2, 3, 20, and 43 treated with ceftriaxone, levofloxacin, sitafloxacin, and extended-release azithromycin (azithromycin-SR), respectively. We assessed microbiological outcomes in 54 men and clinical outcomes in 46 with H. influenzae–positive monomicrobial nongonococcal urethritis. We determined minimum inhibitory concentrations (MICs) of 6 antimicrobial agents for 59 pretreatment isolates. H. influenzae was eradicated from the men treated with ceftriaxone, levofloxacin, or sitafloxacin. The eradication rate with azithromycin-SR was 85.3%. The disappearance or alleviation of urethritis symptoms and the decreases in leukocyte counts in first-voided urine were significantly associated with the eradication of H. influenzae after treatment. For the isolates, ceftriaxone, levofloxacin, sitafloxacin, azithromycin, tetracycline, and doxycycline MICs were ≤0.008–0.25, 0.008–0.5, 0.001–0.008, 0.12–1, 0.25–16, and 0.25–2 μg/mL, respectively. The azithromycin MICs for 3 of 4 strains persisting after azithromycin-SR administration were 1 μg/mL. H. influenzae with an azithromycin MIC of 1 μg/mL increased chronologically. H. influenzae showed good responses to the chemotherapies for urethritis. The significant associations of the clinical outcomes of the chemotherapies with their microbiological outcomes suggested that H. influenzae could play pathogenic roles in urethritis. All isolates, except for one with decreased susceptibility to tetracyclines, were susceptible to the examined agents. However, the increase in H. influenzae with an azithromycin MIC of 1 μg/mL might threaten efficacies of azithromycin regimens on H. influenzae–positive urethritis.Keywords
This publication has 13 references indexed in Scilit:
- Urethritis-associated Pathogens in Urine from Men with Non-gonococcal Urethritis: A Case-control StudyActa Dermato-Venereologica, 2016
- Male non‐gonococcal urethritis: From microbiological etiologies to demographic and clinical featuresInternational Journal of Urology, 2016
- Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty IncidentMMWR. Recommendations and Reports, 2015
- Isolation ofHaemophilus influenzaeandHaemophilus parainfluenzaein urethral exudates from men with acute urethritis: a descriptive study of 52 cases: Table 1Sexually Transmitted Infections, 2015
- Development and clinical application of an InvaderPlus® assay for the detection of genital mycoplasmasJournal of Infection and Chemotherapy, 2015
- A single 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritisJournal of Antimicrobial Chemotherapy, 2014
- Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first editionJournal of Infection and Chemotherapy, 2011
- Etiologies of Nongonococcal Urethritis: Bacteria, Viruses, and the Association with Orogenital ExposureThe Journal of Infectious Diseases, 2006
- Haemophilus influenzae and Haemophilus parainfluenzae in Nongonococcal UrethritisThe Journal of Infectious Diseases, 1986
- Haemophilus influenzae in genitourinary tract infectionsDiagnostic Microbiology and Infectious Disease, 1983